INIS
phosphates
100%
kidneys
93%
fibroblasts
68%
growth factors
68%
diseases
62%
levels
43%
cardiovascular diseases
37%
hypothesis
25%
comparative evaluations
18%
bones
18%
therapy
18%
minerals
18%
nmr imaging
18%
absorption
12%
reduction
12%
diet
12%
data
12%
metabolism
12%
fibrosis
12%
risks
12%
nicotinamide
12%
proposals
12%
patients
12%
assessments
12%
death
12%
biological markers
12%
hypertrophy
12%
phenotype
6%
inflammation
6%
fractures
6%
blood
6%
binders
6%
cardiovascular system
6%
niacin
6%
animals
6%
lanthanum carbonates
6%
precursor
6%
yields
6%
roads
6%
range
6%
testing
6%
diffusion
6%
metabolites
6%
gadolinium
6%
failures
6%
Medicine and Dentistry
Phosphate
81%
Fibroblast Growth Factor 23
68%
Chronic Kidney Disease
62%
Cardiovascular Disease
37%
Combination Therapy
25%
Marker
18%
Ethinylestradiol Plus Megestrol Acetate
18%
Placebo
18%
Mineral Metabolism
12%
Biological Marker
12%
Phosphate Intake
12%
Bone Turnover
12%
Left Ventricular Hypertrophy
12%
Nicotinamide
12%
Serum
12%
Clotiazepam
12%
Diet
12%
Assessment
12%
Deterioration
12%
Parent
12%
Death
12%
Patient
12%
Gadolinium
6%
Metabolite
6%
Disease Exacerbation
6%
Diffusion MRI
6%
Cardiovascular System
6%
Niacin
6%
Calcitriol
6%
Kidney Fibrosis
6%
Lanthanum Carbonate
6%
Fracture
6%
Phenotype
6%
Phosphate Binder
6%
Blood Oxygenation
6%
Fibrosis
6%
Cardiac Magnetic Resonance Imaging
6%
Parathyroid Hormone
6%
Diastolic Dysfunction
6%
Artery Calcification
6%
Magnetic Resonance Imaging
6%
Precursor
6%
Proteinuria
6%
Renal Failure
6%
Introspection
6%
Mineral
6%
Bone Metabolism
6%
Complication
6%